Krane Funds Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$563K	Buy	9,531 +2,157	+29%	+$126K	0.02%	116
2025 Q4	$398K	Sell	7,374 -1,679	-19%	-$80.8K	0.01%	123
2025 Q3	$392K	Sell	9,053 -396	-4%	-$18.5K	0.01%	112
2025 Q2	$437K	Buy	9,449 +1,359	+17%	+$66.7K	0.02%	76
2025 Q1	$493K	Sell	8,090 -998	-11%	-$58.2K	0.01%	50
2024 Q4	$514K	Sell	9,088 -1,665	-15%	-$93K	0.02%	39
2024 Q3	$556K	Buy	10,753 +829	+8%	+$38.9K	0.02%	41
2024 Q2	$412K	Sell	9,924 -502	-5%	-$22.5K	0.02%	62
2024 Q1	$550K	Buy	10,426 +5,038	+94%	+$257K	0.02%	40
2023 Q4	$276K	Sell	5,388 -4,330	-45%	-$227K	0.01%	87
2023 Q3	$564K	Buy	9,718 +795	+9%	+$48.7K	0.02%	47
2023 Q2	$571K	Buy	8,923 +228	+3%	+$15.3K	0.03%	45
2023 Q1	$609K	Sell	8,695 -183	-2%	-$12.9K	0.03%	50
2022 Q4	$639K	Sell	8,878 -1,489	-14%	-$112K	0.03%	44
2022 Q3	$737K	Sell	10,367 -110	-1%	-$7.98K	0.04%	51
2022 Q2	$807K	Sell	10,477 -3,112	-23%	-$237K	0.03%	58
2022 Q1	$992K	Buy	13,589 +7,143	+111%	+$480K	0.04%	62
2021 Q4	$402K	Sell	6,446 -814	-11%	-$47.8K	0.01%	174
2021 Q3	$430K	Sell	7,260 -10,436	-59%	-$687K	0.01%	171
2021 Q2	$1.18M	Buy	17,696 +11,701	+195%	+$763K	0.04%	67
2021 Q1	$378K	Sell	5,995 -4,574	-43%	-$285K	0.01%	263
2020 Q4	$656K	Buy	10,569 +4,080	+63%	+$251K	0.03%	118
2020 Q3	$391K	Sell	6,489 -158	-2%	-$9.51K	0.02%	138
2020 Q2	$391K	Sell	6,647 -1,472	-18%	-$88K	0.02%	120
2020 Q1	$453K	Sell	8,119 -763	-9%	-$46.6K	0.02%	107
2019 Q4	$570K	Buy	+8,882	New	+$509K	0.04%	93